Abstract
Cerebral ischemia is one of the major causes of morbidity and mortality in the Western world. Despite extensive research, adequate therapies are still elusive. Neuronal degeneration and death are hallmarks of stroke / ischemia. Understanding how the death machinery executes neuronal death in ischemia will provide therapeutic targets. Key to the death machinery are caspases: the family of cell death proteases. While much data has been published regarding caspase involvement in models of ischemia, the pathways have not been thoroughly defined. The specification of the caspases critical for death has been hampered by the use of nonspecific reagents. Thus many conclusions about specificity are unwarranted. In this review we discuss how caspases can be measured and review the existing knowledge of the roles of specific caspases in ischemia. We also discuss approaches to determining the molecules that execute ischemic death.
Keywords: caspases, neuronal death, apoptosis, ischemia, stroke, iaps
Current Drug Targets - CNS & Neurological Disorders
Title: Caspase Function in Neuronal Death: Delineation of the Role of Caspases in Ischemia
Volume: 4 Issue: 1
Author(s): Giselle F. Prunell, Valerie A. Arboleda and Carol M. Troy
Affiliation:
Keywords: caspases, neuronal death, apoptosis, ischemia, stroke, iaps
Abstract: Cerebral ischemia is one of the major causes of morbidity and mortality in the Western world. Despite extensive research, adequate therapies are still elusive. Neuronal degeneration and death are hallmarks of stroke / ischemia. Understanding how the death machinery executes neuronal death in ischemia will provide therapeutic targets. Key to the death machinery are caspases: the family of cell death proteases. While much data has been published regarding caspase involvement in models of ischemia, the pathways have not been thoroughly defined. The specification of the caspases critical for death has been hampered by the use of nonspecific reagents. Thus many conclusions about specificity are unwarranted. In this review we discuss how caspases can be measured and review the existing knowledge of the roles of specific caspases in ischemia. We also discuss approaches to determining the molecules that execute ischemic death.
Export Options
About this article
Cite this article as:
Prunell F. Giselle, Arboleda A. Valerie and Troy M. Carol, Caspase Function in Neuronal Death: Delineation of the Role of Caspases in Ischemia, Current Drug Targets - CNS & Neurological Disorders 2005; 4 (1) . https://dx.doi.org/10.2174/1568007053005082
DOI https://dx.doi.org/10.2174/1568007053005082 |
Print ISSN 1568-007X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-007X |
Related Articles
-
Ginkgo biloba as an Alternative Medicine in the Treatment of Anxiety in Dementia and other Psychiatric Disorders
Current Drug Metabolism Impact of Sex Hormone Metabolism on the Vascular Effects of Menopausal Hormone Therapy in Cardiovascular Disease
Current Drug Metabolism Selenium in the Therapy of Neurological Diseases. Where is it Going?
Current Neuropharmacology Proteomic Analysis of the Kidney in Rat Biliary Cirrhosis
Current Proteomics Meet Our Editorial Board Member:
Central Nervous System Agents in Medicinal Chemistry Role of Oxidative Stress in Polycystic Ovary Syndrome
Current Women`s Health Reviews Tailoring NO Donors Metallopharmaceuticals: Ruthenium Nitrosyl Ammines and Aliphatic Tetraazamacrocycles
Current Medicinal Chemistry Targeting Inflammation in Primary Cardiovascular Prevention
Current Pharmaceutical Design Spinal Cord Ischemia/Injury
Current Pharmaceutical Design Sildenafil Improves Vascular Endothelial Structure and Function in Renovascular Hypertension
Current Pharmaceutical Biotechnology Mitochondria in Chronic Liver Disease
Current Drug Targets Chemistry and Biological Activities of Buxus Alkaloids
Current Bioactive Compounds Chemokines as Therapeutic Targets for Renal Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Matrix Metalloproteinases as Valid Clinical Target
Current Pharmaceutical Design Neuropharmacology of Stress-Induced Mucosal Inflammation: Implications for Inflammatory Bowel Disease and Irritable Bowel Syndrome
Current Molecular Medicine Stem Cell Therapy for the Treatment of Myocardial Infarction
Current Pharmaceutical Design Advances in Inhibitors of FXa
Current Drug Targets MICA Gene and Relevance to Immune Responses in Organ Transplants and Inflammatory, Tumoral and Autoimmune Diseases
Current Immunology Reviews (Discontinued) Soluble Epoxide Hydrolase Inhibitors and their Potential for Treatment of Multiple Pathologic Conditions
Current Medicinal Chemistry Cell Immunity in Coronary Artery Disease (CAD)
Current Immunology Reviews (Discontinued)